CHO Pharma, Inc.

NT$74.20As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6586Healthcare
Country Taiwan
PE (Fwd) •••
TSR 9Y CAGR (0.12%)
Div yield —
ROE (10.71%)
Biotechnology
Beta (5Y) 1.03
PE TTM —
TSR TTM 112.61%
Mkt cap NT$15.88B
ROIC (7.49%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$78
4.77%
(58.88%)
Hold 1|5|6|6|10
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
1.38
1.45
1.59
1.57
31.56%
39.33%
39.35%
27.28%
RevenueNT$B
1.629
1.678
1.723
1.748
14.04%
11.83%
8.89%
8.38%
Peers (US$486.7M)
Cap (US$)
PE
465.7M
—
Capital
TTM
5Y
10Y
Leveragex
3.186
0.067
0.065
EBIT/Intx
1.168
0.381
0.404
Own earn%
1258.65
(120.83)
(77.44)
Sh yield%
17.16
28.20
29.13
Owners
Insiders/Inst%
2.40
40.08
Short interest%
0.62
SBC / revenue%
5.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
13–19
$1 testx
−0.1
Incr. ROIC%
17